1Khan BV, Parthasarathy SS, Alexander RW, et al. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells[J]. J Clin Invest, 1995, 95(3) : 1262-1270.
2Ortego M, Bustos C, Hernandez Presa MA, et al. Atorvastatin reduces NF-KappaB activation and chemokine, expression in vascular smooth muscle cells and mononuclear cells [ J ]. Atherosclerosis, 1999, 147(2) : 253-261.
3Wassmann S, Lames U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normecholesterolemic hypertension via reduced production of reactive oxygen species [ J ]. Hypertension, 2001, 37(6) : 1450-1457.
4Hema'ndez-Presa MA; Martin-Ventura JL, Ortego M, et al. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells[ J]. Atherosclerosis, 2002, 160 ( 1 ) : 49-58.
5Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reative protein with cerivastatin among 785 patients with primary hyperolesterolemia[J]. Circulation, 2001, 103(9) : 1191-1193.
4Szarszoi O,Maly J,Ostddal P,et al. Effect of acute and chronic simvastatin treatment on post-ischemic contractile dysfunction in isolated rat heart[J]. Physiol Res, 2008,57 (5) : 793-796.
5Chan AW, Bhatt DL, Chew DP, et al. Relation of inflammation and benefit of statins after percutaneous coronary in interventions[J]. Circulation, 2003,107(13) : 1750-1756.
6Wassmann S, Faul A, Hennen B, et al. Rapid effect of 3- hydroxy-3-methyl glutaryl coenzyme a reductase inhibition on coronary endothelial function [J]. Circ Res, 2003,93 ( 9 ) : e98-103.
7Feron O, Dessy C, Desager JP, et al. Hydroxy-methylglutaryl coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance[J]. Circulation, 2001,103 ( 1 ) : 113-118.
8Szarszoi O, Maly J, Ostadal P,et al. Effect of acute and chronic simvastatin treatment on post-ischemic contractile dysfunction in isolated rat heart [J] . Physiol Res, 2008, 57(5) : 793-796.
9Kaeng W. Lee, Gregory Y. H. Lip, Muzahir Tayebjee, et al.Circulating endoth elial cells, von Willebrand factor, interleukin-6, and prognosis in patients with a- cute coronary syndromes[J]. Blood, 2005, 105(2) : 526-532.
10Gianetti J, Parri MS, Sbrana S, et al . Ptatelet activation predicts recurrent is- chemic events after percutaneous coronary angioplasty: a 6 months prospective study[J]. Thromb Res, 2006, 118(4):487-493.
